Brian Millham - Nov 22, 2024 Form 4 Insider Report for Salesforce, Inc. (CRM)

Role
President and COO
Signature
/s/ Sarah Dale, Attorney-in-Fact for Brian Millham
Stock symbol
CRM
Transactions as of
Nov 22, 2024
Transactions value $
-$1,662,016
Form type
4
Date filed
11/22/2024, 08:20 PM
Previous filing
Oct 30, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRM Common Stock Options Exercise $380K +2.04K $186.51 2.04K Nov 22, 2024 Direct F1
transaction CRM Common Stock Options Exercise $434K +2.02K +99.07% $215.17 4.06K Nov 22, 2024 Direct F1
transaction CRM Common Stock Options Exercise $460K +2.11K +51.96% $218.21 6.16K Nov 22, 2024 Direct F1
transaction CRM Common Stock Options Exercise $2.08M +8.65K +140.31% $240.95 14.8K Nov 22, 2024 Direct F1
transaction CRM Common Stock Sale -$5.02M -14.8K -100% $338.95 0 Nov 22, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRM Non-qualified Stock Option (Right to Buy) Options Exercise $0 -2.04K -3.45% $0.00 57.1K Nov 22, 2024 Common Stock 2.04K $186.51 Direct F1, F2
transaction CRM Non-qualified Stock Option (Right to Buy) Options Exercise $0 -2.02K -20% $0.00 8.07K Nov 22, 2024 Common Stock 2.02K $215.17 Direct F1, F3
transaction CRM Non-qualified Stock Option (Right to Buy) Options Exercise $0 -2.11K -5.88% $0.00 33.7K Nov 22, 2024 Common Stock 2.11K $218.21 Direct F1, F4
transaction CRM Non-qualified Stock Option (Right to Buy) Options Exercise $0 -8.65K -25% $0.00 25.9K Nov 22, 2024 Common Stock 8.65K $240.95 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 As indicated by the checkbox above, this transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2023.
F2 Option is exercisable and vests over four years at the rate of 25% on March 22, 2024, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.
F3 Option is exercisable and vests over four years at the rate of 25% on March 22, 2022, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.
F4 Option is exercisable and vests over four years at the rate of 25% on March 22, 2023, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.
F5 Option is exercisable and vests over four years at the rate of 25% on February 22, 2022, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.